AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Acquiring Company
Merck KGaA Darmstadt Germany
Acquired Company
Bio-Techne
Hesse
MinneapolisManufacturingBiotechnologyHealth CareLife ScienceManufacturingBiotechnologyHealth CareScience And EngineeringBiotechnology ResearchDescription
Bio-Techne shareholders have approved the acquisition by Merck KGaA, Darmstadt, Germany. The approval marks a significant step towards the completion of the transaction, expected to close by late 2026 or early 2027. The merger aims to enhance life sciences offerings by combining both companies' strengths. Merck KGaA will bring additional resources and capabilities to Bio-Techne's existing portfolio.
Fundz sees it the moment Merck KGaA Darmstadt Germany makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Bio-Techne?
Bio-Techne was acquired by Merck KGaA Darmstadt Germany, based in Hesse. The deal was reported on September 23, 2026. Merck KGaA is a leading science and technology company known for its innovative solutions in healthcare, life sciences, and performance materials. Merck KGaA Darmstadt Germany is privately held and operates in Manufacturing.
When did Merck KGaA Darmstadt Germany acquire Bio-Techne?
Merck KGaA Darmstadt Germany's acquisition of Bio-Techne was reported on September 23, 2026. Bio-Techne shareholders have approved the acquisition by Merck KGaA, Darmstadt, Germany. The approval marks a significant step towards the completion of the transaction, expected to close by late 2026 or early 2027. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Bio-Techne do?
Bio-Techne (NASDAQ: TECH) is a company that has decided to discontinue its FBS products. It is publicly traded (TECH), operating in Manufacturing, and is based in Minneapolis.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.